Hepatic steatosis is associated with lower levels of physical activity measured via accelerometry

Obesity

Volumn 23, Issue 6, 2015, Pages 1259-1266

  Long, Michelle T ^a,b   Pedley, Alison ^b   Massaro, Joseph M ^b,c   Hoffmann, Udo ^d   Esliger, Dale W ^e   Vasan, Ramachandran S ^a,b   Fox, Caroline S ^b,f   Murabito, Joanne M ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c Boston University   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELEROMETRY; ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FATTY LIVER; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; INTRAABDOMINAL FAT; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONALCOHOLIC FATTY LIVER; PHYSICAL ACTIVITY; PREVALENCE; UNITED STATES; WAIST CIRCUMFERENCE; AGED; CLINICAL TRIAL; MIDDLE AGED; MOTOR ACTIVITY; MULTICENTER STUDY; OBESITY, ABDOMINAL; PROCEDURES; RADIOGRAPHY; SEDENTARY LIFESTYLE;

ACCELEROMETRY; ADULT; AGED; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY, ABDOMINAL; PREVALENCE; SEDENTARY LIFESTYLE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84929963650     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21058     Document Type: Article

References (40)

1. Younossi ZM, Stepanova M, Afendy M, et al., Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011; 9: 524-530 e521; quiz e560.
2. Adams LA, Lymp JF, St. Sauver J, et al., The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 2005; 129: 113-121.
3. Stepanova M, Rafiq N, Makhlouf H, et al., Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci 2013; 58: 3017-3023.
4. Chalasani N, Younossi Z, Lavine JE, et al., The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005-2023.
5. Johnson NA, Sachinwalla T, Walton DW, et al., Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 2009; 50: 1105-1112.
6. Keating SE, Hackett DA, George J, Johnson NA,. Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis. J Hepatol 2012; 57: 157-166.
7. Shojaee-Moradie F, Baynes KC, Pentecost C, et al., Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia 2007; 50: 404-413.
8. Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S,. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology 2012; 55: 1738-1745.
9. Goodpaster BH, Delany JP, Otto AD, et al., Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: A randomized trial. JAMA 2010; 304: 1795-1802.
10. Hickman IJ, Byrne NM, Croci I, et al., A pilot randomised study of the metabolic and histological effects of exercise in non-alcoholic steatohepatitis. J Diabetes Metab 2013; 4: 1-10.
11. Krasnoff JB, Painter PL, Wallace JP, Bass NM, Merriman RB,. Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. Hepatology 2008; 47: 1158-1166.
12. Kistler KD, Brunt EM, Clark JM, et al., Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol 2011; 106: 460-468; quiz 469.
13. Bae JC, Suh S, Park SE, et al., Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults. PloS One 2012; 7: e46819.
14. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, et al., Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study. Hepatology 2008; 48: 1791-1798.
15. Gerber L, Otgonsuren M, Mishra A, et al., Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: A population-based study. Aliment Pharmacol Ther 2012; 36: 772-781.
16. Borman MA, Ladak F, Crotty P, et al., The Fatty Liver Index has limited utility for the detection and quantification of hepatic steatosis in obese patients. Hepatology Int 2012; 7: 592-599.
17. Wilmot EG, Edwardson CL, Achana FA, et al., Sedentary time in adults and the association with diabetes, cardiovascular disease and death: Systematic review and meta-analysis. Diabetologia 2012; 55: 2895-2905.
18. van der Ploeg HP, Chey T, Korda RJ, Banks E, Bauman A,. Sitting time and all-cause mortality risk in 222 497 Australian adults. Arch Intern Med 2012; 172: 494-500.
19. Henson J, Yates T, Biddle SJ, et al., Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia 2013; 56: 1012-1020.
20. 2008 Physical Activity Guidelines for Americans. In: US Department of Health and Human Services (HHS) OoDPaHP (ed). www.health.gov/paguidelines, 2008.
21. Glazer NL, Lyass A, Esliger DW, et al., Sustained and shorter bouts of physical activity are related to cardiovascular health. Med Sci Sports Exerc 2013; 45: 109-115.
22. Roseman DA, Hwang S-J, Manders ES, et al., Renal artery calcium, cardiovascular risk factors, and indexes of renal function. Am J Cardiol 2014; 113: 156-161.
23. Speliotes EK, Massaro JM, Hoffmann U, et al., Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham Heart Study. Hepatology 2010; 51: 1979-1987.
24. Prince SA, Adamo KB, Hamel ME, Hardt J, Connor Gorber S, Tremblay M,. A comparison of direct versus self-report measures for assessing physical activity in adults: A systematic review. Int J Behav Nutr Phys Act 2008; 5: 56.
25. Dyrstad SM, Hansen BH, Holme IM, Anderssen SA,. Comparison of self-reported versus accelerometer-measured physical activity. Med Sci Sports Exerc 2014; 46: 99-106.
26. Tucker JM, Welk GJ, Beyler NK,. Physical activity in U.S.: Adults compliance with the Physical Activity Guidelines for Americans. Am J Prev Med 2011; 40: 454-461.
27. Dunstan DW, Kingwell BA, Larsen R, et al., Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diabetes Care 2012; 35: 976-983.
28. Bradley RL, Jeon JY, Liu FF, Maratos-Flier E,. Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice. Am J Physiol Endocrinol Metab 2008; 295: E586-594.
29. Mikus CR, Rector RS, Arce-Esquivel AA, et al., Daily physical activity enhances reactivity to insulin in skeletal muscle arterioles of hyperphagic Otsuka Long-Evans Tokushima Fatty rats. J Appl Physiol 2010; 109: 1203-1210.
30. Johnson NA, George J,. Fitness versus fatness: Moving beyond weight loss in nonalcoholic fatty liver disease. Hepatology 2010; 52: 370-381.
31. Solomon TP, Haus JM, Marchetti CM, Stanley WC, Kirwan JP,. Effects of exercise training and diet on lipid kinetics during free fatty acid-induced insulin resistance in older obese humans with impaired glucose tolerance. Am J Physiol Endocrinol Metab 2009; 297: E552-559.
32. Fox CS, Massaro JM, Hoffmann U, et al., Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48.
33. Pou KM, Massaro JM, Hoffmann U, et al., Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: The Framingham Heart Study. Circulation 2007; 116: 1234-1241.
34. Koutsari C, Basu R, Rizza RA, Nair KS, Khosla S, Jensen MD,. Nonoxidative free fatty acid disposal is greater in young women than men. J Clin Endocrinol Metab 2011; 96: 541-547.
35. Lazo M, Hernaez R, Eberhardt MS, et al., Prevalence of nonalcoholic fatty liver disease in the United States: The Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2013; 178: 38-45.
36. Browning JD, Szczepaniak LS, Dobbins R, et al., Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 2004; 40: 1387-1395.
37. Blaak E,. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 2001; 4: 499-502.
38. Carter SL, Rennie C, Tarnopolsky MA,. Substrate utilization during endurance exercise in men and women after endurance training. Am J Physiol Endocrinol Metab 2001; 280: E898-907.
39. Park SH, Kim PN, Kim KW, et al., Macrovesicular hepatic steatosis in living liver donors: Use of CT for quantitative and qualitative assessment. Radiology 2006; 239: 105-112.
40. Ioannou GN, Boyko EJ, Lee SP,. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol 2006; 101: 76-82.